Synthetic peptides for treatment of allergies and asthma
Synthetic peptides for treatment of allergies and asthma
Sectors
Healthcare
Life Sciences
First Invested
1993
Early
Company Status
IPO/Public
About
Team
Portfolio
Insights
About
Team
Portfolio
Insights
NEA Portfolio: Dura Pharmaceuticals